Genes regulating levels of ω‐3 long‐chain polyunsaturated fatty acids are associated with alcohol use disorder and consumption, and broader externalizing behavior in humans

BACKGROUND: Individual variation in the physiological response to alcohol is predictive of an individual's likelihood to develop alcohol use disorder (AUD). Evidence from diverse model organisms indicates that the levels of long‐chain polyunsaturated omega‐3 fatty acids (ω‐3 LC‐PUFAs) can modulate the behavioral response to ethanol and therefore may impact the propensity to develop AUD. While most ω‐3 LC‐PUFAs come from diet, humans can produce these fatty acids from shorter chain precursors through a series of enzymatic steps. Natural variation in the genes encoding these enzymes has been shown to affect ω‐3 LC‐PUFA levels. We hypothesized that variation in these genes could contribute to the susceptibility to develop AUD. METHODS: We identified nine genes (FADS1, FADS2, FADS3, ELOVL2, GCKR, ELOVL1, ACOX1, APOE, and PPARA) that are required to generate ω‐3 LC‐PUFAs and/or have been shown or predicted to affect ω‐3 LC‐PUFA levels. Using both set‐based and gene‐based analyses we examined their association with AUD and two AUD‐related phenotypes, alcohol consumption, and an externalizing phenotype. RESULTS: We found that the set of nine genes is associated with all three phenotypes. When examined individually, GCKR, FADS2, and ACOX1 showed significant association signals with alcohol consumption. GCKR was significantly associated with AUD. ELOVL1 and APOE were associated with externalizing. CONCLUSIONS: Taken together with observations that dietary ω‐3 LC‐PUFAs can affect ethanol‐related phenotypes, this work suggests that these fatty acids provide a link between the environmental and genetic influences on the risk of developing AUD.